Polli E - Search Results

1

Structural alterations of the NF-kappa B transcription factor lyt-10 in lymphoid malignancies.

Fracchiolla NS, Lombardi L, Salina M, Migliazza A, Baldini L, Berti E, Cro L, Polli E, Maiolo AT, Neri A. Fracchiolla NS, et al. Among authors: polli e. Oncogene. 1993 Oct;8(10):2839-45. Oncogene. 1993. PMID: 8378093

2

Multiple genetic lesions in laryngeal squamous cell carcinomas.

Fracchiolla NS, Pignataro L, Capaccio P, Trecca D, Boletini A, Ottaviani A, Polli E, Maiolo AT, Neri A. Fracchiolla NS, et al. Among authors: polli e. Cancer. 1995 Mar 15;75(6):1292-301. doi: 10.1002/1097-0142(19950315)75:6<1292::aid-cncr2820750611>3.0.co;2-b. Cancer. 1995. PMID: 7882279

3

Frequent p53 gene involvement in splenic B-cell leukemia/lymphomas of possible marginal zone origin.

Baldini L, Fracchiolla NS, Cro LM, Trecca D, Romitti L, Polli E, Maiolo AT, Neri A. Baldini L, et al. Among authors: polli e. Blood. 1994 Jul 1;84(1):270-8. Blood. 1994. PMID: 8018922 Free article.

4

p53 gene mutations in multiple myeloma are associated with advanced forms of malignancy.

Neri A, Baldini L, Trecca D, Cro L, Polli E, Maiolo AT. Neri A, et al. Among authors: polli e. Blood. 1993 Jan 1;81(1):128-35. Blood. 1993. PMID: 8417784 Free article.

5

"In vitro" biological activity of a synthetic pentapeptide of myeloid cells.

Foa P, Chillemi F, Lombardi L, Lonati S, Ciani A, Maiolo AT, Polli EE. Foa P, et al. Among authors: polli ee. Basic Appl Histochem. 1987;31(3):337-40. Basic Appl Histochem. 1987. PMID: 3426518 No abstract available.

6

Chronic myelogenous leukemia following radiation therapy for testicular seminoma.

Iurlo A, Foa P, Maiolo AT, Polli EE. Iurlo A, et al. Among authors: polli ee. Blut. 1989 Dec;59(6):503-4. doi: 10.1007/BF00329496. Blut. 1989. PMID: 2597776

7

Inhibitory activity of a synthetic pentapeptide on leukaemic myelopoiesis both in vitro and in vivo in rats.

Foa P, Chillemi F, Lombardi L, Lonati S, Maiolo AT, Polli EE. Foa P, et al. Among authors: polli ee. Eur J Haematol. 1987 Nov;39(5):399-403. doi: 10.1111/j.1600-0609.1987.tb01446.x. Eur J Haematol. 1987. PMID: 3480237

8

Recombinant gamma-interferon as first line therapy for high risk myelodysplastic syndromes. Italian MDS Study Group.

Maiolo AT, Cortelezzi A, Calori R, Polli EE. Maiolo AT, et al. Among authors: polli ee. Leukemia. 1990 Jul;4(7):480-5. Leukemia. 1990. PMID: 2115613 Clinical Trial.

9

No correlation between response and survival in patients with multiple myeloma treated with vincristine, melphalan, cyclophosphamide, and prednisone.

Baldini L, Radaelli F, Chiorboli O, Fumagalli S, Cro L, Segala M, Cesana BM, Polli EE, Maiolo AT. Baldini L, et al. Among authors: polli ee. Cancer. 1991 Jul 1;68(1):62-7. doi: 10.1002/1097-0142(19910701)68:1<62::aid-cncr2820680112>3.0.co;2-6. Cancer. 1991. PMID: 2049754 Clinical Trial.

10

Immunophenotypes in "classical" B-cell chronic lymphocytic leukemia. Correlation with normal cellular counterpart and clinical findings.

Baldini L, Cro L, Cortelezzi A, Calori R, Nobili L, Maiolo AT, Polli EE. Baldini L, et al. Among authors: polli ee. Cancer. 1990 Oct 15;66(8):1738-42. doi: 10.1002/1097-0142(19901015)66:8<1738::aid-cncr2820660816>3.0.co;2-l. Cancer. 1990. PMID: 2208028

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

294 results

Search Page

Filters